August 2010 Briefing - Nephrology
Here are what the editors at HealthDay consider to be the most important developments in Nephrology for August 2010. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
Screening Guidelines Offered for Urinary Tract Conditions
MONDAY, Aug. 30 (HealthDay News) -- The American Urological Association (AUA) has published new guidelines for the screening of siblings and offspring of index patients with vesicoureteral reflux (VUR) and infants with prenatal hydronephrosis (PNH) in the September issue of The Journal of Urology.
Type 1 Diabetes With ESRD Prognosis Has Improved
MONDAY, Aug. 30 (HealthDay News) -- The survival of patients with type 1 diabetes and end-stage renal disease (ESRD) receiving renal replacement therapy (RRT) has improved since 1980, even with an increase in the age of patients starting RRT, according to a study in the August issue of Diabetes Care.
Hemoglobin Variability May Not Affect Mortality in CKD Patients
FRIDAY, Aug. 27 (HealthDay News) -- Variability in hemoglobin (Hb) levels appears to be high in European chronic kidney disease patients on hemodialysis, but this variability does not seem to independently predict mortality risk, according to research published online Aug. 26 in the Journal of the American Society of Nephrology.
Ultrasound May Often Overestimate Renal Stone Size
THURSDAY, Aug. 19 (HealthDay News) -- Ultrasound often overestimates the size of stones in urolithiasis, particularly when the stones are 5 mm or smaller, according to research published in the August issue of Urology.
Kidneys From Cardiac-Death, Brain-Dead Patients Equal
THURSDAY, Aug. 19 (HealthDay News) -- Kidneys transplanted from donors with controlled cardiac death perform as well as organs from brain-dead donors, according to research published online Aug. 19 in The Lancet.
Steroids in Cadaveric Donor Don't Benefit Kidney Recipient
WEDNESDAY, Aug. 18 (HealthDay News) -- Treating deceased kidney donors with corticosteroids in advance of kidney harvesting does not reduce the incidence or duration of acute renal failure (ARF) after transplantation in organ recipients, according to a study in the Aug. 17 issue of the Annals of Internal Medicine.
Totally Tubeless PCNL Effective, Safe in Elderly
WEDNESDAY, Aug. 18 (HealthDay News) -- Totally tubeless (tubeless and stentless) percutaneous nephrolithotomy (PCNL) is routinely used for adults with renal stones, and it appears to be safe, effective, and feasible even in elderly patients, according to research published in the August issue of Urology.
Insurance Type May Affect Kidney Patient Predialysis Care
FRIDAY, Aug. 13 (HealthDay News) -- Kidney disease patients insured by federally-sponsored national health care organizations such as the Department of Veterans Affairs (DVA) and the Department of Defense (DoD) are more likely to begin hemodialysis with an arteriovenous fistula (AVF) than patients with other types of insurance coverage, according to research published online Aug. 12 in the Journal of the American Society of Nephrology.
Proteinuria Prevalent in Injection Drug Users With HIV
FRIDAY, Aug. 13 (HealthDay News) -- Proteinuria is common among injection drug users, especially those who have HIV, according to a study published online Aug. 12 in the Clinical Journal of the American Society of Nephrology.
Patients, Doctors Often Have Communication Discrepancies
WEDNESDAY, Aug. 11 (HealthDay News) -- Hospitalized patients and physicians may have differing beliefs regarding patients' knowledge and aspects of their care, suggesting a need for improved patient-physician communication, according to research published in the Aug. 9/23 issue of the Archives of Internal Medicine.
Industry-Funded Clinical Trials Yield More Positive Outcomes
TUESDAY, Aug. 3 (HealthDay News) -- Drug clinical trials supported by industry are more likely to produce favorable results than trials supported by government or nonprofit/nonfederal organizations, and they are less likely to be published within two years of the study being completed, according to research published in the Aug. 3 issue of the Annals of Internal Medicine.